(FG) F&G Annuities Life - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US30190A1043
FG: Annuities, Insurance, Life Insurance, Fixed Annuities
F&G Annuities & Life Inc. (NYSE:FG) is a prominent provider of fixed annuities and life insurance products in the United States. Established in 1959 and headquartered in Des Moines, Iowa, the company operates as a subsidiary of Fidelity National Financial, Inc., leveraging the stability and resources of its parent organization. F&Gs product portfolio is designed to meet diverse customer needs, offering fixed indexed annuities, multi-year guarantee annuities, and pension risk transfer solutions. Additionally, they provide indexed universal life insurance and institutional funding agreements, catering to both retail and institutional clients.
The companys financial standing is notable, with a market capitalization of approximately $5.85 billion. While the current P/E ratio is 0.00, the forward P/E is 4.86, indicating expected earnings growth. The price-to-book ratio of 1.35 suggests that investors value the companys assets appropriately. With a price-to-sales ratio of 1.00, F&G demonstrates a balanced approach to revenue generation and profitability.
F&Gs strategic position in the market is strengthened by its focus on predictable income products, which are particularly appealing in volatile economic conditions. The inclusion of indexed products allows for controlled market exposure, enhancing appeal to risk-conscious investors. Their expertise in pension risk transfers addresses a critical need for corporations seeking to manage liabilities, positioning F&G as a key player in this growing sector.
As a subsidiary of Fidelity National Financial, F&G benefits from a robust financial framework and extensive industry knowledge, enhancing its competitive edge. This affiliation not only provides operational stability but also access to a broader network and resources, enabling F&G to maintain its position as a reliable and innovative insurer in the U.S. market.
Additional Sources for FG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FG Stock Overview
Market Cap in USD | 5,551m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 2022-12-01 |
FG Stock Ratings
Growth 5y | 61.2% |
Fundamental | -13.9% |
Dividend | 52.0% |
Rel. Strength Industry | -28.5 |
Analysts | 3/5 |
Fair Price Momentum | 39.06 USD |
Fair Price DCF | 346.12 USD |
FG Dividends
Dividend Yield 12m | 2.09% |
Yield on Cost 5y | 5.35% |
Annual Growth 5y | 2.44% |
Payout Consistency | 100.0% |
FG Growth Ratios
Growth Correlation 3m | -17.7% |
Growth Correlation 12m | 75.9% |
Growth Correlation 5y | 85.3% |
CAGR 5y | 51.30% |
CAGR/Max DD 5y | 1.24 |
Sharpe Ratio 12m | 0.18 |
Alpha | -34.21 |
Beta | 2.14 |
Volatility | 43.92% |
Current Volume | 187.3k |
Average Volume 20d | 78.3k |
As of February 23, 2025, the stock is trading at USD 40.18 with a total of 187,343 shares traded.
Over the past week, the price has changed by -14.58%, over one month by -8.41%, over three months by -14.27% and over the past year by -7.04%.
Neither. Based on ValueRay Fundamental Analyses, F&G Annuities Life is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -13.90 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FG as of February 2025 is 39.06. This means that FG is currently overvalued and has a potential downside of -2.79%.
F&G Annuities Life has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold FG.
- Strong Buy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, FG F&G Annuities Life will be worth about 46.9 in February 2026. The stock is currently trading at 40.18. This means that the stock has a potential upside of +16.65%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 47 | 17% |
Analysts Target Price | 47 | 17% |
ValueRay Target Price | 46.9 | 16.7% |